QUIAPEG PHARMAC.H. O.N.

Share · SE0020678159 · A3EJG7 (XSTO)

Overview

No Price

Share Float & Liquidity

Free Float 52,93 %

Shares Float 1,39 B

Shares Outstanding 2,62 B

Company Profile for QUIAPEG PHARMAC.H. O.N. Share

QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.

AI Analysis of QUIAPEG PHARMAC.H. O.N.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of QUIAPEG PHARMAC.H. O.N.

No AI threads available for this company yet.

Company Data

Name QUIAPEG PHARMAC.H. O.N.

Company Quia Pharma AB (publ)

Website https://www.quiapeg.com

Primary Exchange

Frankfurt

WKN A3EJG7

ISIN SE0020678159

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Marcus Bosson

Country Sweden

Currency EUR

Employees 0,0 T

Address Uppsala Business Park, 754 50 Uppsala

IPO Date 2005-06-21

Dividends from 'QUIAPEG PHARMAC.H. O.N.'

Ex-Date	Dividend per Share
30.03.2017	2,39 SEK
06.03.2017	0,13 SEK
09.06.2016	0,26 SEK
07.05.2014	0,11 SEK
26.04.2013	0,22 SEK
27.04.2012	0,22 SEK

Stock Splits

Date	Split
01.08.2023	1:100
10.03.2023	2023:1000
21.08.2020	25:22
27.06.2011	1:20

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	QUIA.ST
Frankfurt	99B0.F

More Shares

Investors who hold QUIAPEG PHARMAC.H. O.N. also have the following shares in their portfolio:

Litman Gregory Funds Trust IMGP Berkshire Dividend Growth ETF ETF

Zhejiang Taitan Co.,Ltd. Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog